Molecular Imaging of the Tumor Microenvironment Reveals the Relationship between Tumor Oxygenation, Glucose Uptake, and Glycolysis in Pancreatic Ductal Adenocarcinoma

Novel multimodal molecular imaging techniques reveal the potential of three interrelated imaging biomarkers to profile the tumor microenvironment and interrelationships of hypoxia, glucose uptake, and glycolysis. Molecular imaging approaches for metabolic and physiologic imaging of tumors have become important for treatment planning and response monitoring. However, the relationship between the physiologic and metabolic aspects of tumors is not fully understood. Here, we developed new hyperpolarized MRI and electron paramagnetic resonance imaging procedures that allow more direct assessment of tumor glycolysis and oxygenation status quantitatively. We investigated the spatial relationship between hypoxia, glucose uptake, and glycolysis in three human pancreatic ductal adenocarcinoma tumor xenografts with differing physiologic and metabolic characteristics. At the bulk tumor level, there was a strong positive correlation between 18F-FDG-PET and lactate production, while pO2 was inversely related to lactate production and 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG) uptake. However, metabolism was not uniform throughout the tumors, and the whole tumor results masked different localizations that became apparent while imaging. 18F-FDG uptake negatively correlated with pO2 in the center of the tumor and positively correlated with pO2 on the periphery. In contrast to pO2 and 18F-FDG uptake, lactate dehydrogenase activity was distributed relatively evenly throughout the tumor. The heterogeneity revealed by each measure suggests a multimodal molecular imaging approach can improve tumor characterization, potentially leading to better prognostics in cancer treatment. Significance: Novel multimodal molecular imaging techniques reveal the potential of three interrelated imaging biomarkers to profile the tumor microenvironment and interrelationships of hypoxia, glucose uptake, and glycolysis.

[1]  Xiaofei Li,et al.  Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy , 2018, Cancer medicine.

[2]  Majbrit M E Larsen,et al.  Combined hyperpolarized 13C-pyruvate MRS and 18F-FDG PET (hyperPET) estimates of glycolysis in canine cancer patients. , 2018, European journal of radiology.

[3]  Chi V Dang,et al.  Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy. , 2017, Trends in cell biology.

[4]  R. Arora,et al.  Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer , 2017, Cell & Bioscience.

[5]  Timothy W. Secomb,et al.  Transport of drugs from blood vessels to tumour tissue , 2017, Nature Reviews Cancer.

[6]  D. Urban,et al.  Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH). , 2017, Journal of medicinal chemistry.

[7]  Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis , 2017, Scientific Reports.

[8]  Gerald C. Chu,et al.  Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism , 2017, Nature Communications.

[9]  Matthew G. Vander Heiden,et al.  Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.

[10]  R. Gillies,et al.  PET and MRI: Is the Whole Greater than the Sum of Its Parts? , 2016, Cancer research.

[11]  Shingo Matsumoto,et al.  Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302 , 2015, Cancer & metabolism.

[12]  E. Taylor,et al.  Regulation of pyruvate metabolism and human disease , 2013, Cellular and Molecular Life Sciences.

[13]  Martin O. Leach,et al.  Model Free Approach to Kinetic Analysis of Real-Time Hyperpolarized 13C Magnetic Resonance Spectroscopy Data , 2013, PloS one.

[14]  A. Haase,et al.  Multimodal Assessment of In Vivo Metabolism with Hyperpolarized [1-13C]MR Spectroscopy and 18F-FDG PET Imaging in Hepatocellular Carcinoma Tumor–Bearing Rats , 2013, The Journal of Nuclear Medicine.

[15]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[16]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[17]  J. Shea,et al.  Phenotype and Genotype of Pancreatic Cancer Cell Lines , 2010, Pancreas.

[18]  C. Van de Wiele,et al.  FDG uptake, a surrogate of tumour hypoxia? , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[20]  Jens Overgaard,et al.  Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Rowan Guide for the Care and Use of Laboratory Animals , 1979 .